Related Experiment Video
Updated: Oct 22, 2025

3D Cell-Printed Hypoxic Cancer-on-a-Chip for Recapitulating Pathologic Progression of Solid Cancer
Published on: January 5, 2021
Technological Advances in Tumor-On-Chip Technology: From Bench to Bedside
Santa Bērziņa1, Alexandra Harrison1, Valérie Taly1
1Centre de Recherche des Cordeliers, INSERM, CNRS SNC 5096, Sorbonne Université, Université de Paris, 75006 Paris, France.
Tumor-on-chip technology offers advanced in vitro cancer research models. Integrating effective analysis tools with these microfluidic devices is crucial for personalized anti-cancer therapies and clinical applications.
Area of Science:
- Biomedical Engineering
- Cancer Research
- Microfluidics
Background:
- Tumor-on-chip technology is a vital in vitro model for cancer research.
- It effectively mimics the in vivo tumor microenvironment, showing promise for translational medicine.
- Potential applications include personalized anti-cancer therapies.
Purpose of the Study:
- To provide an overview of current technological advances in tumor-on-chip generation.
- To review state-of-the-art on-chip analysis tools for microfluidic tumor models.
- To evaluate the progress and potential of patient-derived tumor-on-chip devices in clinical research and personalized medicine.
Main Methods:
- Review of current technological advancements in tumor-on-chip generation.
- Systematic review of on-chip analysis tools for microfluidic tumor models.
- Analysis of progress in tumor-on-chip devices utilizing patient-derived samples.
Main Results:
- Tumor-on-chip technology is advancing rapidly in recapitulating tumor microenvironments.
- Effective analysis tools are essential for enhancing tumor-on-chip functionalities but are often overlooked.
- Patient-derived tumor-on-chip devices show significant potential for clinical research.
Conclusions:
- Tumor-on-chip technology is a powerful tool for cancer research and personalized medicine.
- Coupling advanced generation techniques with robust analysis tools is key to unlocking the full potential of these models.
- Further development of patient-derived tumor-on-chip systems is critical for advancing clinical applications.
More Related Videos
07:26Author Spotlight: Creating Human Vascularized Micro-Tumors as Models for Translational Cancer Research
Published on: September 15, 2023
09:53Quantifying the Brain Metastatic Tumor Micro-Environment using an Organ-On-A Chip 3D Model, Machine Learning, and Confocal Tomography
Published on: August 16, 2020